Left ventricular circulatory support as bridge to heart transplantation in Chagas' disease cardiomyopathy

Artificial Organs

Volumn 31, Issue 4, 2007, Pages 253-258

  Moreira, Luiz Felipe P ^a   Galantier, João ^a   Benício, Anderson ^a   Leirner, Adolfo A ^a   Cestari, Idágene A ^a   Stolf, Noedir A G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chagas' disease; Circulatory support; Right ventricular failure; Ventricular assist device

Indexed keywords

CARDIOLOGY; FIBER OPTIC SENSORS; HEART; PATIENT TREATMENT;

CHAGAS DISEASE; CIRCULATORY SUPPORT; HEART TRANSPLANTATION; LEFT VENTRICULAR; MULTIPLE ORGAN FAILURE; RIGHT VENTRICLE; RIGHT VENTRICULAR; RIGHT VENTRICULAR DYSFUNCTIONS; RIGHT VENTRICULAR FAILURE; VENTRICULAR ASSIST DEVICE;

LEFT VENTRICULAR ASSIST DEVICES;

ADULT; ARTICLE; ASSISTED CIRCULATION; CARDIOGENIC SHOCK; CARDIOMYOPATHY; CHAGAS DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; FEASIBILITY STUDY; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE FUNCTION; HUMAN; MALE; MULTIPLE ORGAN FAILURE; PATIENT SAFETY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SURVIVAL TIME;

EID: 34247125637     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2007.00372.x     Document Type: Article

References (23)

1. Rassi A Jr, Rassi A, Little WC. Chagas' heart disease. Clin Cardiol 2000;23:883-9.
2. Freitas HF, Chizzola PR, Paes AT, Lima AC, Mansur AJ. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease. Int J Cardiol 2005;102:239-47.
3. Rassi A Jr, Rassi A, Little WC, et al. Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med 2006;355:799-808.
4. Bocchi EA, Fiorelli AI. The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. First guidelines group for heart transplantation of the Brazilian Society of Cardiology. Ann Thorac Surg 2001;71: 1833-8.
5. Fiorelli AI, Stolf NAG, Honorato R, et al. Later evolution after cardiac transplantation in Chagas' disease. Transplant Proc 2005;37:2793-8.
6. Bacal F, Silva CP, Bocchi EA, et al. Mychophenolate mofetil increased chagas disease reactivation in heart transplanted patients: comparison between two different protocols. Am J Transplant 2005;5:2017-21.
7. Bocchi EA, Higuchi ML, Vieira ML, et al. Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease. J Heart Lung Transplant 1998;17:399-405.
8. Moreira LFP, Galantier J, Benício A, et al. Clinical perspectives of patients with Chagas cardiomyopathy listed as high priority for heart transplantation. Rev Bras Cir Cardiovasc 2005;20:261-9.
9. Birks EJ, Yacoub MH, Banner NR, Khaghani A. The role of bridge to transplantation: should LVAD patients be transplanted? Curr Opin Cardiol 2004;19:148-53.
10. Bocchi EA, Vieira ML, Fiorelli AI, et al. Hemodynamic and neurohormonal profile during assisted circulation with heterotopic artificial ventricle followed by heart transplantation. Arq Bras Cardiol 1994;62:23-7.
11. Oshiro MS, Hayashida SA, Maizato MJ, et al. Design, manufacturing, and testing of a paracorporeal pulsatile ventricular assist device: Sao Paulo Heart Institute VAD. Artif Organs 1995;19:274-9.
12. Dang NC, Topkara VK, Mercando M, et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant 2006; 25:1-6.
13. Furukawa K, Motomura T, Nose Y. Right ventricular failure after left ventricular assist device implantation: the need for an implantable right ventricular assist device. Artif Organs 2005; 29:369-77.
14. Ochiai Y, McCarthy PM, Smedira NG, et al. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation 2002;106:I198-I202.
15. Schenk S, McCarthy PM, Blackstone EH, et al. Duration of inotropic support after left ventricular assist device implantation: risk factors and impact on outcome. J Thorac Cardiovasc Surg 2006;131:447-54.
16. Nunes MC, Barbosa MM, Brum VA, Rocha MO. Morphofunctional characteristics of the right ventricle in Chagas' dilated cardiomyopathy. Int J Cardiol 2004;94:79-85.
17. Mocelin AO, Issa VS, Bacal F, Guimaraes GV, Cunha E, Bocchi EA. The influence of aetiology on inflammatory and neurohumoral activation in patients with severe heart failure: a prospective study comparing Chagas' heart disease and idiopathic dilated cardiomyopathy. Eur J Heart Fail 2005;7:869-73.
18. Bittner HB, Chen EP, Biswas SS, Van TP, III, Davis RD. Right ventricular dysfunction after cardiac transplantation: primarily related to status of donor heart. Ann Thorac Surg 1999;68: 1605-11.
19. Burkhoff D, Klotz S, Mancini DM. LVAD-induced reverse remodeling: basic and clinical implications for myocardial recovery. J Card Fail 2006;12:227-39.
20. Guarita-Souza LC, Carvalho KA, Woitowicz V, et al. Simultaneous autologous transplantation of cocultured mesenchymal stem cells and skeletal myoblasts improves ventricular function in a murine model of Chagas disease. Circulation 2006; 114:I120-I124.
21. Vilas-Boas F, Feitosa GS, Soares MB, et al. Early results of bone marrow cell transplantation to the myocardium of patients with heart failure due to Chagas disease. Arq Bras Cardiol 2006;87:159-66.
22. Costa Teixeira PB, Goncalves PB, Cestari IA, Leirner AA, Pamplona D. Mechanical behavior and stability of the internal membrane of the InCor ventricular assist device. Artif Organs 2001;25:912-21.
23. Benício A, Moreira LFP, Hayashida S, et al. Analysis of the hemodynamic performance of the InCor ventricular assist device as a substitute for the left heart. Rev Bras Cir Cardiovasc 1999;14:237-46.